• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Full-Time Equivalents in FY 2011

Back to Table of Contents: FY 2011 MDUFMA Financial Report


Table 3 presents FTE levels that support the medical device application review process by FDA organizational component for the last seven years.  This is a measure of paid staff years devoted to device review.  These FTE numbers show Center for Devices and Radiological Health (CDRH), Center for Biologics Evaluation and Research (CBER), Office of Regulatory Affairs (ORA) and FDA Headquarters (HQ), formally known as the Office of the Commissioner, staff transferred to the consolidated shared services organization as if they were still in CDRH, CBER, ORA, and HQ.


Table 3

Process For The Review Of Medical Device Applications Total FTEs

As Of September 30, 2011





 ORGANIZATION 2005 2006 2007 2008 2009 2010 2011
 CDRH 794 765 806 843 853 949 1001
 CBER 87 108 105 109 109 120 120
 ORA 64 65 68 66 60 72 72
 HQ 89 82 92 77 87 89 82
 TOTAL FTE 1,034 1,020  1,071 1,095 1,109 1,230 1,275



In FY 2011 the medical device program experienced a small increase in FTEs over FY 2010.  While the FTEs at CDRH increased slightly, the FTEs at CBER and ORA remained the same.  FDA Headquarters dedicated a lower amount of FTEs to the medical device review process in FY 2011, which is directly related to a decline in overall spending at HQ.

See the section Total Costs of the Process for the Review of Medical Device Applications, in Carryover Balances, for more discussion on the total process costs for MDUFMA.


Next Section: Carryover Balances